Septerna, Inc. financials

SEPN CIK 0001984086

Source: EDGAR filings · Built 2026-06-02T04:01:09Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2024
Free Cash Flow 109.67M -69.57M -41.60M
EBITDA -66.70M -79.42M 2.88M
Working Capital 324.03M 343.98M 105.76M
Net Debt -97.10M -212.72M -75.92M
Operating Margin -148.63% -7518.42% 1374.17%
Net Margin -106.37% -6678.88% 2768.21%
Return on Equity (ROE) -12.80% -17.09% -10.89%
Return on Assets (ROA) -8.20% -15.73% 3.19%
Current Ratio 4.73× 27.77× 16.30×
Debt-to-Equity 0.06× 0.06× -0.33×
Effective Tax Rate -0.02% 0.69% -1.41%
Cash Conversion Ratio -2.25× 0.94× -9.26×
Accruals Ratio -0.27× -0.01× 0.33×
SBC % of Revenue 18.45% 293.21% 1072.85%
CapEx Coverage 212.72× -32.08× -13.45×
Free Cash Flow Per Share $2.48 $-7.03 $-19.11

Valuation Metrics

Concept FY 2025FY 2024FY 2024
P/FCF 11.25×
FCF Yield 8.89%
P/S 27.19× 946.30×
P/B 3.27× 2.42×

Income Statement

Concept FY 2025FY 2024FY 2024
Revenue from Contract with Customer, Excluding Assessed Tax 45.95M 1.07M 151.00K
Research and Development Expense 97.58M 65.34M 35.98M
Operating Expenses 114.25M 81.90M -1.92M
Operating Income (Loss) -68.30M -80.82M 2.08M
Income Tax Expense (Benefit) 12.00K -498.00K 691.00K
Net Income (Loss) Attributable to Parent -48.88M -71.80M 4.18M
Earnings Per Share, Basic $-1.10 $-7.26 $0.29
Weighted Average Number of Shares Outstanding, Basic 44.26M 9.89M 1.93M
Earnings Per Share, Diluted $-1.10 $-7.26 $0.29
Weighted Average Number of Shares Outstanding, Diluted 44.26M 9.89M 2.18M

Balance Sheet

Concept FY 2025FY 2024FY 2024
Cash and Cash Equivalents, at Carrying Value 120.72M 238.20M 88.48M
Assets, Current 410.96M 356.82M 112.68M
Assets 596.19M 456.55M 130.87M
Liabilities, Current 86.93M 12.85M 6.91M
Liabilities 214.26M 36.51M 20.03M
Stockholders' Equity Attributable to Parent 381.93M 420.05M -38.37M
Common Stock, Shares, Outstanding 44.81M 44.42M 3.17M

Cash Flow Statement

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (SEPN CIK 0001984086), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

NMIH

NMI Holdings, Inc.

WABC

WESTAMERICA BANCORPORATION

EBS

EMERGENT BIOSOLUTIONS INC.